Collegium Pharmaceutical, Inc (COLL): Net Income
$62.87M
Year ended 2025-12-31
$47.91M
Trailing 12 months to 2026-06-30
+18.6%
5-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $62.87M | -9.1% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $69.19M | +43.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $48.16M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$25.00M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $71.52M | +167.3% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $26.75M | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | -$22.72M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$39.13M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$74.86M | n/m | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | -$94.18M | n/m | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | -$27.25M | n/m | 2018-03-07, From 2015-01-01 |
| 2014-12-31 | -$17.92M | n/m | 2017-03-10, From 2014-01-01 |
| 2013-12-31 | -$16.20M | n/a | 2016-03-18, From 2013-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $62.87M | -9.1% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $99.65M | -29.4% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $52.60M | n/m |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $30.11M | n/m |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $7.03M | n/m |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $98.09M | -38.5% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | -$38.55M | n/m |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $158.69M | +9.1% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $78.34M | n/m |
Compare COLL, CORT, EBS, ARWR side by side · Screen every company in Pharmaceutical Preparations ↗